Advanced Prostate Cancer Drug May Help at Ear... (surgery. Nor has the surgery which remov...)

Advanced Prostate Cancer Drug May Help at Earlier Stage

Date:5/17/2012

surgery. Nor has the surgery, which removes the entire prostate.

Zytiga blocks production of testosterone, which can promote the growth of prostate cancer cells, but in a different way than established hormonal treatments.

This small, phase 2 trial involved 56 men with an average age of 58, all of whom had had at least three positive biopsies for prostate cancer.

For the first three months, 27 men received the standard hormonal therapy leuprolide alone, followed by leuprolide plus Zytiga for another three months.

The remaining 29 men received the two-drug combination for the whole six months, after which all men in both groups underwent prostate surgery.

One-third of the men who had received leuprolide plus Zytiga for the entire six months saw complete or nearly complete elimination of their cancer.

By comparison, only 15 percent of men in the other group experienced these results, the investigators found.

Those who received the combination for only 12 weeks had much lower response rates.

The participants also received low doses of the steroid prednisone to prevent side effects from Zytiga, although side effects overall were minimal, said Taplin.

It's not clear at this point why some men responded to the combination therapy while others did not, and that is an area that needs to be studied, the researchers said.

"In highly select people who have this aggressive type of prostate cancer, I think this is an important area to investigate," Brooks noted. "We need to figure out which patients would potentially benefit."

According to study author Taplin, the research received some funding from Johnson & Johnson, the maker of Zytiga. She said the drug is currently U.S. Food and Drug Administration-approved for patients with advanced prostate cancer that does not respond to hormone therapy, and costs about $5,000 per month.

The data and conclusions of research presented at medical meet
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Advanced genetic screening method may speed vaccine development
2. Experimental Gel May Help Those With Advanced Parkinsons
3. CYFRA21-1 might be predictive marker in advanced NSCLC
4. Womans Recovery From Advanced Melanoma Could Help Guide Research
5. Study shows advance in using patients own tumor-fighting cells to knock back advanced melanoma
6. Canadian scientist develops worlds most advanced drug to protect the brain after a stroke
7. Study finds injectable treatment for blood clots in advanced cancer patients increases
8. Fogarty Institute for Innovation launches advanced endovascular training fellowship
9. Experimental Drugs Do Battle Against Advanced Prostate Cancer
10. Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
11. RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer

Post Your Comments:

Related Image:

Advanced Prostate Cancer Drug May Help at Earlier Stage

(Date:5/19/2013)... (PRWEB) May 19, 2013 Healthcare leaders ... 19-22, 2013, at the Walt Disney World Swan and ... in supply chain innovation, care delivery and healthcare reform ... dynamic in all healthcare markets, with consolidation, ... the conversation,” said Todd Ebert, Amerinet president and CEO. ...

(Date:5/19/2013)... May 19, 2013 The muscles in ... their functionality and one of the biggest and most ... nervous system. The peripheral system comprises of peripheral nerves ... cord. These nerves ensure that the limbs and hands, ... when these nerves get damaged due to trauma or ...

(Date:5/19/2013)... TX (PRWEB) May 19, 2013 ... analysis for US, UK, Spain, Japan, Italy, Germany ... to the molecular diagnostics laboratory practice, as well ... trends with significant market impact during the next ... DNA probe and biochip technologies, test formats, detection ...

(Date:5/19/2013)... Colorado (PRWEB) May 19, 2013 Farming ... first seed in the ground 10,000 years ago. Most ... increased farm productivity by using genetically engineered seeds and ... now seeing a backlash to these techniques due to ... and chemicals and a corresponding surge in interest in ...

(Date:5/19/2013)... (PRWEB) May 19, 2013 Agora Health Limited ... that covers guides on how to increase memory power ... memory training method that helps people re-new their entire health ... and beat depression caused by a fatigued mind. In addition, ... razor sharp for a lifetime. The author claimed that this ...

Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2 Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3 Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2

[0] Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery [0] Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy [0] Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com [0] Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics [0] How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review

... Revenue increases 7 percent to $23 billion -- Diluted earnings per ... EPS from continuing operations ... $0.90 per share -- Full year Non-GAAP ... -- Renews three-year, multi-billon-dollar Walgreens contract, DUBLIN, Ohio, Jan. 29 ...

... 29 , ... -- Net Sales of $1.07 billion represents an increase of 15% reported ... (10% constant currency), -- Diluted EPS were $1.12 reported, ... $1.18 adjusted, an increase of 16% over the prior year ...

... from American College of Surgeons helps patients do the,research ... 29 In today,s information-rich,environment, American consumers are stepping ... more prepared than ever. But according to results of ... consumer survey,when it comes to needing an operation, patients ...

... 29 The American Academy,of Family Physicians is pleased ... interest in improving access to health care. In doing,so, ... system reform., Improving Americans, ability to pay for ... health system that provides care to all, ensures the,financial ...

... Bill Novelli,made the following statement today in response ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070209/NYF043LOGO ), "We hope ... beyond,rhetoric and towards bipartisan solutions that are fair ... together, openly,debate all available options, and solve our ...

... CEO Bill Novelli,made the following statement about today,s ... (Nunez & Perata) by the California State Senate,Committee ... failed to seize an opportunity to,fix their broken ... the,status quo - which includes millions of uninsured ...

Cardinal Health Reports Second Quarter Results, Revises EPS Outlook Zimmer Reports Fourth Quarter and 2007 Financial Results Survey Says: Patients Prep Harder for Vacation than for an Operation AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform Statement by AARP CEO Bill Novelli on President Bush's State of the Union AARP Disappointed in Senate's Inability to Pass Health Care Reform

(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease. Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million. The ...

(Date:5/16/2013)... 2013 Today, the National Patient Advocate Foundation acknowledges ... of Representatives recently approved a bill that would prohibit ... higher out-of-pocket fees for newer, more expensive oral anti-cancer ... more severe side-effects. However, the bill was amended to ... continue to be a barrier to patients with cancer ...

(Date:5/16/2013)... , May 16, 2013 Amgen (NASDAQ: AMGN ... on Tuesday, May 21, 2013, at the Sheraton New York ... beginning at 10:00 a.m. Eastern Daylight Time. Joseph ... Research and Development at Amgen, will present at the conference. ... Events Calendar on Amgen,s website, www.amgen.com , under Investors. ...

Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3

[0] AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease [0] National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill [0] Amgen To Present At The UBS Global Life Sciences Conference

... 2011 Healthpoint today announced the launch of a ... Biotherapeutics, along with an updated brandmark and corporate tagline, ... is designed to communicate the company,s commitment to scientific ... contribute to improved outcomes and quality of life for ...

... Md., Feb. 23, 2011 The Cystic Fibrosis Foundation and ... development that targets the defective protein that causes cystic fibrosis, ... The trial was designed to evaluate patients age ... a CF mutation called G551D. The study included 161 patients ...

Cached Medicine Technology:Healthpoint Launches New Corporate Identity 2 Healthpoint Launches New Corporate Identity 3 Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2 Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3

Healthpoint Launches New Corporate Identity Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation

... CCR Medical's Articulating Tip ... units in the Industry. The ... intubation by providing an improved ... Conventional and Fiber Optic styles. ...

German Style MacIntosh Fiber Optic Blade Laryngoscopes...

CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....

Medicine Products:

Fiber Optic Articulating Tip Laryngoscope Handles German Style MacIntosh Fiber Optic Blade Laryngoscopes Phillips American Profile Fiberoptic Laryngoscopes Wis-Hipple/Wisconsin American Profile Fiberoptic Laryngoscopes